Global Herpes Simplex Virus Infections Market to Reach $6.6 Billion by 2030
The global market for Herpes Simplex Virus Infections estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2022-2030.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.6% CAGR
The Herpes Simplex Virus Infections market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.Select Competitors (Total 13 Featured) -
- Admedus Limited
- Agenus Inc.
- Aicuris Anti-infective Cures Gmbh
- Asahi Kasei Corporation
- Chimerix Inc.
- Clinigen Group Plc
- Daewoong Pharmaceutical Co., Ltd.
- F. Hoffmann-la Roche Ltd.
- Glaxosmithkline Plc
- Maruho Co. Ltd.
- Merck
- Mylan
- Novartis
- Sanofi Pasteur
- Teva Pharmaceutical Industries Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admedus Limited
- Agenus Inc.
- Aicuris Anti-infective Cures Gmbh
- Asahi Kasei Corporation
- Chimerix Inc.
- Clinigen Group Plc
- Daewoong Pharmaceutical Co., Ltd.
- F. Hoffmann-la Roche Ltd.
- Glaxosmithkline Plc
- Maruho Co. Ltd.
- Merck
- Mylan
- Novartis
- Sanofi Pasteur
- Teva Pharmaceutical Industries Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 269 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.8 Billion |
Forecasted Market Value ( USD | $ 6.6 Billion |
Compound Annual Growth Rate | 4.1% |
Regions Covered | Global |